Why GQG, Imugene, Mirvac, and Temple & Webster Shares Are Pushing Higher

The Motley FoolFeb 13 21:02 ET

Imugene Therapy Achieves Two Complete Responses in Patients With Blood Cancer, Shares Rise Past 8%

MT NewswiresFeb 13 20:41 ET

Which ASX 200 Healthcare Share Will Pay the Best Dividend Yield in 2025?

The Motley FoolFeb 5 21:53 ET

Imugene Receives A$11.7 Million R&D Tax Refund

Investing.com Jan 12 17:16 ET

Imugene Receives A$11.7 Million R&D Tax Refund | ASX:IMU, OTC:IUGNF

Proactive InvestorsJan 12 17:16 ET

Imugene Ltd: Imugene Receives $11.7m R&D Tax Refund

ASXJan 9 21:31 ET · Announcements